🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase I trial studies side effects and best dose of pevonedistat and b...
Status
Terminated
Location
Moffitt Cancer Center-International Plaza
Start Date
2019-06-20
Trial ID
NCT03772925
Treatments Being Tested
This phase I trial studies the side effects and best dose of pevonedistat w...
Status
Active Not Recruiting
Location
City of Hope Medical Center
Start Date
2018-04-27
Trial ID
NCT03479268
Treatments Being Tested
This screening and multi-sub-study Phase 1b/2 trial will establish a method...
Status
Recruiting
Location
Mayo Clinic Arizona
Start Date
2016-11
Trial ID
NCT03013998
Treatments Being Tested
The purpose of this study is to evaluate the safety and tolerability of pev...
Status
Completed
Location
Multiple Locations
Start Date
2016-05-16
Trial ID
NCT02782468
This phase I trial studies the side effects and best dose of pevonedistat w...
Status
Completed
Location
Children's Hospital of Alabama
Start Date
2018-01-11
Trial ID
NCT03323034
Treatments Being Tested
Based on the investigators' preclinical data, the combination of pevonedist...
Status
Terminated
Location
Washington University School of Medicine
Start Date
2018-04-23
Trial ID
NCT03386214
Treatments Being Tested
The purpose of this study is to assess the mass balance (that is, cumulativ...
Status
Completed
Location
Magyar Honvédség Egészségügyi Központ Onkológiai osztály
Start Date
2017-05-11
Trial ID
NCT03057366
Treatments Being Tested
The purpose of this study is to test any good and bad effects of activity p...
Status
Terminated
Location
Memorial Sloan Kettering at Basking Ridge
Start Date
2017-10-05
Trial ID
NCT03319537
Treatments Being Tested
Participants in the expanded access program are adults with higher-risk mye...
Status
No Longer Available
Location
Multiple Locations
Start Date
TBD
Trial ID
NCT04484363
Treatments Being Tested
Background: \- MLN4924 is an experimental cancer drug. It may help kill ly...
Status
Withdrawn
Location
Multiple Locations
Start Date
2011-07-15
Trial ID
NCT01415765
Treatments Being Tested